🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alberto Mendoza‐Ticona

Lycotec (United Kingdom)

ORCID: 0000-0002-2571-2894

Also affiliated with EsSALUD

MedicineEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.

4 citations

Isabelle R. Weir, Kimberly K. Scarsi, Alberto Mendoza‐Ticona, Samuel Pierre, Luke Hall +30 more

2 citations

Gustavo E. Velásquez, Russell R. Kempker, Marjorie Z. Imperial, Eric L. Nuermberger, Susan E. Dorman +22 more

15 citations

Neel R. Gandhi, Soyeon Kim, Michael D. Hughes, Vidya Mave, Alberto Mendoza‐Ticona +13 more

11 citations

Anne‐Marie Demers, Soyeon Kim, Sara McCallum, Kathleen D. Eisenach, Michael D. Hughes +14 more

7 citations

Xingye Wu, Soyeon Kim, Katie McIntire, Linda Naini, Michael D. Hughes +21 more

N/A
0DataRank · unranked
2 citations

Fahd Naufal, Alberto Mendoza‐Ticona, Elin M. Svensson, Isabelle R. Weir, Kimberly K. Scarsi +4 more